ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668494 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668494; 2) Community: the network communities that were significantly associated with the response to NSC 668494; 3) Molecule: the relationships between components within communities and NSC 668494; 4) MDR: the compounds that were significantly associated with the NSC 668494.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0401206532535671 -0.15863285
NSC 720134 Null 0.0401206532535671 -0.046529767
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0401206532535671 0.25940818
NSC 725098 Null 0.0401206532535671 0.49657692
NSC 726217 Combretastatin A4-analogue 0.0401206532535671 0.44755434
NSC 732205 Null 0.0401206532535671 0.36286652
NSC 732492 Null 0.0401206532535671 -0.23620104
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0401206532535671 0.56599008
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.0401206532535671 0.29504717
NSC 743695 Null 0.0401206532535671 0.095099493
Total:100  Current:89    [First] [Prev] [Next] [Last]